Paper41210169
Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions.
Suuring M and 13 others. Mol Ther Methods Clin Dev, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions. Papers, record 41210169. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41210169
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20930086 | Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. | Clin J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/20930086 | PubMed |
| 2 | 10898515 | IL-10 induces apoptosis in human monocytes involving the CD95 receptor/ligand pathway. | Eur J Immunol | 2000 | https://conductscience.org/library/papers/10898515 | PubMed |
| 3 | 32433241 | Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients. | Transplantation | 2021 | https://conductscience.org/library/papers/32433241 | PubMed |
| 4 | 23369513 | Cell therapy using tolerogenic dendritic cells in transplantation. | Transplant Res | 2012 | https://conductscience.org/library/papers/23369513 | PubMed |
| 5 | 24704576 | Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up. | Clin Immunol | 2014 | https://conductscience.org/library/papers/24704576 | PubMed |
| 6 | 31990685 | Phase I trial of donor-derived modified immune cell infusion in kidney transplantation. | J Clin Invest | 2020 | https://conductscience.org/library/papers/31990685 | PubMed |
| 7 | 20083662 | Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. | J Immunol | 2010 | https://conductscience.org/library/papers/20083662 | PubMed |
| 8 | 29099853 | mixOmics: An R package for 'omics feature selection and multiple data integration. | PLoS Comput Biol | 2017 | https://conductscience.org/library/papers/29099853 | PubMed |
| 9 | 26015970 | Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer. | Mol Ther Methods Clin Dev | 2014 | https://conductscience.org/library/papers/26015970 | PubMed |
| 10 | 15037011 | The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function. | Mech Ageing Dev | 2004 | https://conductscience.org/library/papers/15037011 | PubMed |
| 11 | 21073328 | Novel findings in drug-induced dendritic cell tolerogenicity. | Int Rev Immunol | 2010 | https://conductscience.org/library/papers/21073328 | PubMed |
| 12 | 36137752 | Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients. | J Am Soc Nephrol | 2023 | https://conductscience.org/library/papers/36137752 | PubMed |
| 13 | 34298983 | Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34298983 | PubMed |
| 14 | 30566879 | The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases. | Immunity | 2018 | https://conductscience.org/library/papers/30566879 | PubMed |
| 15 | 22634620 | Induction of prolonged asthma tolerance by IL-10-differentiated dendritic cells: differential impact on airway hyperresponsiveness and the Th2 immunoinflammatory response. | J Immunol | 2012 | https://conductscience.org/library/papers/22634620 | PubMed |
| 16 | 26606968 | Type 1 diabetes immunotherapy using polyclonal regulatory T cells. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26606968 | PubMed |
| 17 | 19420134 | Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. | FASEB J | 2009 | https://conductscience.org/library/papers/19420134 | PubMed |
| 18 | 29520275 | Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand? | Front Immunol | 2018 | https://conductscience.org/library/papers/29520275 | PubMed |
| 19 | 31801055 | Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis. | Cell Metab | 2019 | https://conductscience.org/library/papers/31801055 | PubMed |
| 20 | 17548617 | Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity. | J Immunol | 2007 | https://conductscience.org/library/papers/17548617 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939510 | Source-to-Output Integration of Archived Evidence from an Immunoregulatory-Conditioned Human PBMC Extracellular Preparation. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939510 | PubMed |
| 42807017 | Sustained microparticle-mediated intracellular immunomodulation enhances tolerogenic dendritic cell stability and antigen-specific Treg induction. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807017 | PubMed |
| 42792710 | Short-Chain Fatty Acids at the Crossroads of Microbiota, Immunometabolism, and Inflammation. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792710 | PubMed |
| 42183236 | Regulatory T cell therapy in solid organ transplantation: mechanisms, translational progress, and remaining barriers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183236 | PubMed |
| 41789058 | Taming autoimmune thyroiditis: cellular immunomodulation through MSCs, Tregs, and tolDCs. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789058 | PubMed |
| 41362289 | Tailoring monocyte-derived tolerogenic cell therapies to the needs; what's in a name? | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41362289 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41210169
GET https://conductscience.org/api/papers/v1/41210169/references?page=2